Wang, Shunyi
Kuai, Yihe
Lin, Simin
Li, Li
Gu, Quliang
Zhang, Xiaohan
Li, Xiaoming
He, Yajun
Chen, Sishuo
Xia, Xiaoru
Ruan, Zhang
Lin, Caixia
Ding, Yi
Zhang, Qianqian
Qi, Cuiling
Li, Jiangchao
He, Xiaodong
Pathak, Janak L.
Zhou, Weijie
Liu, Side
Wang, Lijing
Zheng, Lingyun https://orcid.org/0000-0003-0676-3765
Funding for this research was provided by:
National Natural Science Foundation of China (31571178, 31771578, 92068206)
the Guangdong Key Research and Development Plan (2019B020234003)
Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Cancer (2020B121201004)
Article History
Received: 22 June 2022
Accepted: 16 February 2023
First Online: 29 March 2023
Declarations
:
: All samples were collected with informed consent from patients, and all related procedures were performed with the approval of the internal review and ethics boards of People’s Hospital of Baoan District of Shenzhen (Approval Number: BYL20220401) and Nanfang Hospital. All animal experiments were carried out in accordance with the "Guidelines for the Care and Use of Laboratory Animals of Guangdong Pharmaceutical University" and were approved by the Experimental Animal Ethics Committee of Guangdong Pharmaceutical University (Approval Number: Gdpulac2017026).
: Not applicable.
: The authors declare that they have no competing interests.